BioStock: Saniona’s founder on 10 years of history and the future
Today marks the 10th anniversary of biotech company Saniona being founded in Denmark. The company started with only preclinical assets and has now grown to have three programs in clinical stages of development and a U.S.-based executive team with a razor-sharp focus on developing and commercializing rare disease drugs. BioStock reached out to the company’s founder and current Chief Scientific Officer, Jørgen Drejer, to get his view of the transformation the company has undergone over the past decade and his thoughts on the future.
Read the full interview with Jørgen Drejer at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/